2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis

Personalised medicine, new discoveries and studies on rare exposures or outcomes require large samples that are increasingly difficult for any single investigator to obtain. Collaborative work is limited by heterogeneities, both what is being collected and how it is defined. To develop a core set for data collection in rheumatoid arthritis (RA) research which (1) allows harmonisation of data collection in future observational studies, (2) acts as a common data model against which existing databases can be mapped and (3) serves as a template for standardised data collection in routine clinical practice to support generation of research-quality data. A multistep, international multistakeholder consensus process was carried out involving voting via online surveys and two face-to-face meetings. A core set of 21 items (‘what to collect’) and their instruments (‘how to collect’) was agreed: age, gender, disease duration, diagnosis of RA, body mass index, smoking, swollen/tender joints, patient/evaluator global, pain, quality of life, function, composite scores, acute phase reactants, serology, structural damage, treatment and comorbidities. The core set should facilitate collaborative research, allow for comparisons across studies and harmonise future data from clinical practice via electronic medical record systems.

[1]  W. Dixon,et al.  Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature , 2016, Arthritis Research & Therapy.

[2]  M. Hetland,et al.  The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO , 2016, Clinical epidemiology.

[3]  P. Tugwell,et al.  Core Outcome Set–STAndards for Reporting: The COS-STAR Statement , 2016, PLoS medicine.

[4]  W. Dixon,et al.  Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative , 2016, Annals of the rheumatic diseases.

[5]  W. Dixon,et al.  Consistency and Utility of Data Items Across European Rheumatoid Arthritis Clinical Cohorts and Registers , 2015, Arthritis care & research.

[6]  M. Dougados,et al.  2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations , 2014, Annals of the rheumatic diseases.

[7]  D. Symmons,et al.  Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology , 2014, Annals of the rheumatic diseases.

[8]  A. Silman,et al.  EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria , 2013, Annals of the rheumatic diseases.

[9]  David T Felson,et al.  UvA-DARE (Digital Academic Repository) American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials , 2011 .

[10]  P Tugwell,et al.  Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. , 2008, Arthritis and rheumatism.

[11]  M. Suarez‐Almazor,et al.  Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. , 2007, The Journal of rheumatology.